Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2
Journal of the Royal Society of Medicine · 2023
DOI: 10.1177/01410768231203936 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Royal Society of Medicine, 2023. Verfasst von I Chalmers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Evidence-Based Medicine, University of Oxford, OX2 6HX, UK. Hauptthemen laut MEDLINE: Research Design, Intention. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
By the late 1950s, the key role played by the Medical Research Council (MRC) in the development of controlled clinical trials – and of Hill’s leadership specifically – had become widely recognised. The example that had been set by the MRC during the 1950s led the Council for International Organizations of Medical Sciences (CIOMS) to invite Hill to plan and chair a conference on ‘Controlled Clinical Trials’. The conference was convened under the joint auspices of the UN Educational, Scientific and Cultural Organisation (UNESCO) and the World Health Organization (WHO) ‘to discuss the principles, organization and scope of “controlled clinical trials”, which must be carried out if new methods or preparations used for the treatment of disease are to be accurately assessed clinically
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Evidence-Based Medicine, University of Oxford, OX2 6HX, UK.
- Department of Mathematics, Aston University, Birmingham, B4 7ET, UK.
- Institute for Evidence Based Healthcare, Bond University, Queensland, QLD 4226, Australia.
- Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CR ESS), F-75004 Paris, France.
- 2 Reading Road, Wallingford OX10 9DP, UK.
Zitieren
APA
Chalmers, I., Matthews, R., Glasziou, P., Boutron, I., & Armitage, P. (2023). Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2. Journal of the Royal Society of Medicine. https://doi.org/10.1177/01410768231203936
Vancouver
Chalmers I, Matthews R, Glasziou P, Boutron I, Armitage P. Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2. Journal of the Royal Society of Medicine. 2023. doi:10.1177/01410768231203936
BibTeX
@article{Chalmers2023,
author = {Chalmers, I and Matthews, R and Glasziou, P and Boutron, I and Armitage, P},
title = {Trial analysis by treatment allocated or by treatment received? Origins of ‘the intention-to-treat principle’ to reduce allocation bias: Part 2},
journal = {Journal of the Royal Society of Medicine},
year = {2023},
doi = {10.1177/01410768231203936}
}
EUVIMED